Loxosceles gaucho Venom-Induced Acute Kidney Injury - In Vivo and In Vitro Studies

Carregando...
Imagem de Miniatura
Citações na Scopus
16
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Autores
LUCATO JR., Rui V.
BARBARO, Katia C.
MENDES, Gloria E.
BAPTISTA, Maria A. S. F.
CURY, Patricia M.
SCHOR, Nestor
Citação
PLOS NEGLECTED TROPICAL DISEASES, v.5, n.5, article ID e1182, 5p, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Accidents caused by Loxosceles spider may cause severe systemic reactions, including acute kidney injury (AKI). There are few experimental studies assessing Loxosceles venom effects on kidney function in vivo. Methodology/Principal Findings: In order to test Loxosceles gaucho venom (LV) nephrotoxicity and to assess some of the possible mechanisms of renal injury, rats were studied up to 60 minutes after LV 0.24 mg/kg or saline IV injection (control). LV caused a sharp and significant drop in glomerular filtration rate, renal blood flow and urinary output and increased renal vascular resistance, without changing blood pressure. Venom infusion increased significantly serum creatine kinase and aspartate aminotransferase. In the LV group renal histology analysis found acute epithelial tubular cells degenerative changes, presence of cell debris and detached epithelial cells in tubular lumen without glomerular or vascular changes. Immunohistochemistry disclosed renal deposition of myoglobin and hemoglobin. LV did not cause injury to a suspension of fresh proximal tubules isolated from rats. Conclusions/Significance: Loxosceles gaucho venom injection caused early AKI, which occurred without blood pressure variation. Changes in glomerular function occurred likely due to renal vasoconstriction and rhabdomyolysis. Direct nephrotoxicity could not be demonstrated in vitro. The development of a consistent model of Loxosceles venom-induced AKI and a better understanding of the mechanisms involved in the renal injury may allow more efficient ways to prevent or attenuate the systemic injury after Loxosceles bite.
Palavras-chave
Referências
  1. Abdulkader RCRM, 2008, SEMIN NEPHROL, V28, P373, DOI 10.1016/j.semnephrol.2008.04.006
  2. McDade J, 2010, J PEDIATR-US, V156, P155, DOI 10.1016/j.jpeds.2009.07.021
  3. Swanson DL, 2006, CLIN DERMATOL, V24, P213, DOI 10.1016/j.clindermatol.2005.11.006
  4. Barbaro KC, 2005, TOXICON, V45, P489, DOI 10.1016/j.toxicon.2004.12.009
  5. Vanholder R, 2000, J AM SOC NEPHROL, V11, P1553
  6. Veiga SS, 2000, HISTOCHEM J, V32, P397, DOI 10.1023/A:1004031019827
  7. Ospedal KZ, 2002, INT J EXP PATHOL, V83, P287, DOI 10.1046/j.1365-2613.2002.00241.x
  8. Hogan CJ, 2004, ANN EMERG MED, V44, P608, DOI 10.1016/j.annemergmed.2004.08.028
  9. Chaim OM, 2006, TOXICOL APPL PHARM, V211, P64, DOI 10.1016/j.taap.2005.05.015
  10. de Souza AL, 2008, TOXICON, V51, P151, DOI 10.1016/j.toxicon.2007.08.011
  11. Luciano MN, 2004, J HISTOCHEM CYTOCHEM, V52, P455
  12. da Silva PH, 2004, TOXICON, V44, P693, DOI 10.1016/j.toxicon.2004.07.012
  13. BARBARO KC, 1992, TOXICON, V30, P331, DOI 10.1016/0041-0101(92)90873-4
  14. Barbaro KC, 1996, BRAZ J MED BIOL RES, V29, P1491
  15. de Castroa I, 2004, TOXICON, V43, P833, DOI 10.1016/j.toxicon.2004.03.015
  16. CAMPALANS LA, 1973, REV URUG PATOL CLIN, V11, P13
  17. Domingos MO, 2003, TOXICON, V42, P471, DOI 10.1016/S0041-0101(03)00200-9
  18. Elbahlawan LM, 2005, PEDIATR EMERG CARE, V21, P177
  19. Franca FOD, 2002, T ROY SOC TROP MED H, V96, P287
  20. GONZALEZ C, 1986, REV MED CHILE, V114, P1155
  21. Malaque Ceila Maria Sant'Ana, 2002, Revista do Instituto de Medicina Tropical de Sao Paulo, V44, P139, DOI 10.1590/S0036-46652002000300005
  22. Paludo KS, 2006, TOXICON, V47, P844, DOI 10.1016/j.toxicon.2006.02.006
  23. RODRIGUEZ LEM, 1964, AN FAC MED LIMA, V47, P419
  24. SALAZAR E, 1978, PEDIATRIA-SANTIAGO, V21, P337
  25. Schenone F H, 2003, REV MED CHILE, V131, P437
  26. SCHENONE FH, 1989, REV INST MED TROP SP, V31, P403
  27. Schenone FH, 2001, REV CHIL PEDIATR, V72, P100
  28. Sezerino UM, 1998, T ROY SOC TROP MED H, V92, P546, DOI 10.1016/S0035-9203(98)90909-9
  29. SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
  30. Tambourgi DV, 1998, TOXICON, V36, P391, DOI 10.1016/S0041-0101(97)00063-9
  31. Tavares FL, 2004, HUM EXP TOXICOL, V23, P477, DOI 10.1191/0960327104ht475oa
  32. TAYLOR EH, 1966, SOUTHERN MED J, V59, P1209
  33. van den Berg CW, 2007, J THROMB HAEMOST, V5, P989, DOI 10.1111/j.1538-7836.2007.02382.x
  34. Zambrano A, 2005, REV MED CHILE, V133, P219, DOI 10.4067/S0034-98872005000200011